Arquivamento - Art. 36 §1° da LPI
#11.2
08/20/2024
RPI 2798
Application data
Number
112019007100Type
Filing
Publication
PCT
US2017055628 The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 08/20/2024. We update with every new RPI gazette, published weekly.
Applicants
TCR2 THERAPEUTICS INC.
US
Inventors
G. S. (pessoa física)
US
P. B. (pessoa física)
US
R. H. (pessoa física)
US
IPC Classification
Priority claims
US
62/405,551 · 10/07/2016
US
62/510,108 · 05/23/2017
Abstract
Trata-se de proteínas de fusão (TFPs) de receptor de célula T (TCR), células T geneticamente modificadas para expressar uma ou mais TFPs e métodos de uso das mesmas para o tratamento de doenças, incluindo câncer.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.2
08/20/2024
RPI 2798
#8.6
Referente à 7ª anuidade.
07/30/2024
RPI 2795
#6.23
04/09/2024
RPI 2779
#15.35
10/05/2021
RPI 2648
#1.3
06/25/2019
RPI 2529
#1.1
04/16/2019
RPI 2519
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.